Jens Pedersen

Jens Pedersen

    Member of:

    • Internal Medicine: Endocrinology


    1. 2022
    2. Published

      Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial

      Hvistendahl, M. K., Naimi, R. M., Hansen, S. H., Rehfeld, Jens Frederik, Kissow, Hannelouise, Pedersen, Jens, Dragsted, Lars Ove, Sonne, D. P., Knop, Filip Krag & Jeppesen, Palle Bekker, 2022, In: Journal of Parenteral and Enteral Nutrition. 46, 4, p. 923-935 13 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

    ID: 5326